Barclays’s Idexx Laboratories IDXX Stock Holding History

Barclays’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-20,000	Closed	-$12.4M	–	4411
2021 Q3	$12.4M	Buy	+20,000	New	+$13.4M	0.01%	1074
2018 Q4	–	Sell	-1,300	Closed	-$325K	–	7100
2018 Q3	$325K	Sell	1,300 -21,100	-94%	-$5.12M	﹤0.01%	4615
2018 Q2	$4.88M	Buy	22,400 +21,500	+2,389%	+$4.43M	﹤0.01%	1743
2018 Q1	$172K	Buy	900 +700	+350%	+$129K	﹤0.01%	4960
2017 Q4	$31K	Hold	200	–	–	﹤0.01%	6041
2017 Q3	$31K	Buy	200 +100	+100%	+$15.8K	﹤0.01%	5591
2017 Q2	$16K	Buy	+100	New	+$16.2K	﹤0.01%	5889

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays's IDXX Position: Q1 2026 in Review

Barclays reduced its Idexx Laboratories (IDXX) stake by 11% in Q1 2026, selling an estimated $15.2M and leaving 187,715 shares worth $105M. The position accounts for 0.03% of the portfolio, ranked #474.

Barclays first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $229M in Q3 2024. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Barclays held 187,715 shares of Idexx Laboratories worth $105M as of Q1 2026.
Barclays sold 23,723 Idexx Laboratories shares in Q1 2026, an estimated $15.2M.
Idexx Laboratories made up 0.03% of Barclays's portfolio in Q1 2026, its #474 holding.
Barclays first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
Barclays's Idexx Laboratories position peaked at $229M in Q3 2024.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.